The results of our gene silencing experiments demonstrated that TACSTD2 is involved in the maintenance of the proper cellular localization of two TJ proteins that are essential for HCV entry, CLDN1 and OCLN, both in hepatoma cells and in primary human hepatocytes. Here, CLDN1 is linked to hepatocellular carcinoma.